Somewhere something incredible
is waiting to be known
What we do
Our fundamental aim is offering to woman and men all over the world a better quality of life.
We give physicians effective tools supporting their clinical practice.
Our products boast a preview experience on the Italian market and proved efficacy in several clinical studies.
To make these products available worldwide we establish trade relationships of out-licensing with all the Companies, little, medium and big ones, that believe in our mission and would like to be part of this innovative process.
Our company has the aim to ensure the success of every Partner, that’s why we offer them all our know-how, instruments and support. They have to only let be driven along the way.
We surely want to add value to the Group, spreading Lo.Li.Pharma brand and purpose.
This our commitment has been the guide of the Company in the past and it will be forever.
Subscribe to our newsletter
to be among the first to receive useful information and exclusive offers. You can request cancellation at any time.
News from the Lo.Li. World
CPHI Frankfurt 2022
We are thrilled to announce that our company will be participating in the upcoming CPHI Frankfurt exhibition, which will take place on 1-3 November 2023. This event is a great opportunity for us to showcase our latest products, meet with industry experts, and network...
The Pakistani market is ready for ALAPREG®
Our partner Galaxy Pharma Pvt. has trusted us once again and has marked another important milestone by distributing our product ALERACT® under the brand ALAPREG®. The product launched in the Pakistani market in January. Galaxy Pharma was established in 2003, and today...
Biguanelle™ has been launched in Tunisia
Biguanelle™ Vaginal Suppositories is now available in Tunisia under the same brand name distributed by our partner Artemis Pharma. The company was founded in 2011 and despite its young age on the pharmaceutical market, Artemis has emerged in Tunisia for its high-speed...
Xyminal® now available in Pakistan
We are pleased to announce another important goal achieved. Xyminal® is now available in the Pakistan market under the brand name SEMEVAG, distributed by our partner Galaxy Pharma Pvt. Ltd.We thank our partner for trusting our company. Let's keep on growing!
Deplesin® : Strategic Partnerships Meet a Huge Unmet Need for Bipolar Disorder Patients
Rome, Italy (January 12, 2022) Lo.Li. Pharma International announced a new strategic partnering plan for their new product, Deplesin®, which meets a huge unmet need for bipolar disorder (BD) patients while emphasizing corporate commitments to innovation and increasing...